Drug Tests Services Market Disclosing Latest Developments and Technology Advancements 2023 to 2030 | Health Street, First Advantage, Drug Testing Services Auckland Ltd.

Published October 26, 2023

The Drug Tests Services market is a vital segment within the healthcare and diagnostics industry, providing testing solutions to detect the presence of drugs and substances in individuals, making it crucial for medical, legal, and employment purposes. This market encompasses various testing methods, including urine, blood, hair, and saliva tests, which are conducted in clinical settings, laboratories, and workplaces. Market research in this domain is essential to understand the evolving landscape of drug testing, including changes in drug policies, advances in testing technologies, and the competitive dynamics in a field that plays a critical role in public health and safety.

“The Drug Tests Services market is estimated to grow at a CAGR of 16.8% between 2023 and 2030.”

Get a free Sample Copy of Drug Tests Services Market  


Scope Of Drug Tests Services Market

The scope of the Drug Tests Services market research covers a wide range of aspects, including market size, growth projections, competitive landscape analysis, pricing models, regulatory considerations, and emerging testing technologies. It also delves into the specific applications of drug testing, such as workplace testing, sports testing, and clinical testing, as well as regional variations in drug testing policies and market dynamics. This comprehensive market overview provides valuable insights for healthcare providers, diagnostic laboratories, employers, and stakeholders interested in understanding and addressing the evolving landscape of drug testing in the Drug Tests Services market.

Most Prominent Players in the Market are Health Street, First Advantage, Drug Testing Services Auckland Ltd., US Drug Test Centers, U.S. Mobile Health Exams, Eurofins Scientific, Sterling, EBI, National Drug Screening, Meridian HealthCare, Clinical Labs, Randox Testing Services, Cansford Labs, DISA, Dynacare, Lake Region Healthcare, Cisive, Floyd Corporate Health

Product Type Insights

The consumables segment dominated the market in 2020 with a revenue share of 34.3%. The increasing launch of advanced consumables that provide improved solutions to make testing easy, accurate, and fast have accelerated the market growth. For instance, in August 2019, MedTest Dx, Inc. introduced Clinitox Calibrators and Controls at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting. These calibrators and controls perform confirmation testing for laboratories to eliminate measurement of steps and manage controls and certifications, need to acquire and set-up materials, and multiple handling.

The services segment accounted for the second-largest revenue share in 2020. An increase in strategic initiatives being undertaken by various companies such as acquisitions, collaborations, and partnerships to support public safety and government agencies, has propelled the segmental growth. In August 2020, Averhealth acquired drug testing services of Treatment Assessment Screening Center (TASC). Averhealth is expected to provide enhanced substance use monitoring services for TASC’s clients.

Sample Type Insights

The urine samples segment dominated the market and accounted for the largest revenue share of 40.8% in 2020. The segment is projected to grow at the fastest rate during the forecast period. This high growth can be attributed to the fact that urine samples are the most commonly used sample type to detect the presence of illicit substances. However, adulteration is becoming highly common in urine samples to produce a false-negative test result, which can adversely impact market growth.

On the other hand, the oral fluid sample segment accounted for the significant market share as it is a quicker and less invasive sample to collect at the roadside. According to NCBI 2020 study, a survey conducted among staff as well as patients concluded that oral fluid samples are preferred over urine samples as they help save time and maintain dignity, regardless of the extra costs.

Drug Type Insights

The cannabis/marijuana segment dominated the drug testing market and accounted for the largest revenue share of 25.9% in 2020. This can be attributed to the fact that marijuana or cannabis is the most commonly used illicit substance in key markets, thus creating a high demand for its testing kits and instruments. According to the Substance Abuse and Mental Health Services Administration, in 2018, the most commonly used illicit drug in the U.S. was marijuana, which was used by about 43.5 million people.

The Opioids segment held the second-largest revenue share in 2020. This high share can be attributed to increased opioid crises in key markets including North America and the introduction of innovative opioid testing solutions. In July 2017, Alere Inc., a subsidiary of Abbott Laboratories, launched Alere iCup Rx Drug Screen. This rapid point-of-care urine test developed for the detection of the most commonly abused prescription medications such as buprenorphine, benzodiazepines, opiates, methadone, and oxycodone.

End-use Insights

Drug testing laboratories dominated the market and held the largest revenue share of 36.0% in 2020. This high share can be attributed to their wide acceptance due to their accurate results. Drug testing laboratories can test for the presence of any illicit substance, which is not possible with rapid tests. Additional advantages of drug testing laboratories include the availability of sophisticated equipment, such as HPLC and spectroscopy, and trained personnel for conducting tests for effective results. Therefore, laboratories provide testing results with more sensitivity and specificity as compared to rapid tests.

Workplaces are projected to be the fastest-growing segment over the forecast period owing to the rising use of substance abuse screening in pre-employment as well as random drug tests to ensure drug-free premises. Moreover, in case of workplace accidents, drug tests can be used to check if the accident happened under influence of drugs, thus removing the responsibility of the employer for damages. Companies spend over USD 3,750 million on drug testing.

This report segments the Drug Tests Services Market on the basis of Types are:

Blood Tests

Urine Drug Tests

Hair Drug Testing

Alcohol Testing


On the basis of Application, the Drug Tests Services Market is segmented into:




Have Any Questions Regarding Global Drug Tests Services Market Report, Ask Our Experts@-


Unlocking Regional Dynamics: In-Depth Insights into Drug Tests Services Market Trends by Geography:

The drug testing services market demonstrates regional diversity, with North America leading the sector and capturing the largest share of approximately 40%. This dominance can be attributed to stringent workplace drug testing regulations, a robust healthcare system, and a well-established drug testing industry. Europe follows with a 30% market share, driven by similar regulatory requirements and growing awareness of drug abuse prevention in workplaces. The Asia-Pacific region holds around 20% of the market share, with increasing adoption of drug testing services due to expanding corporate sectors and heightened safety concerns. Latin America and the Middle East/Africa collectively make up the remaining 10%, with potential for growth as they adopt more stringent workplace drug testing policies.

Get Exclusive Offer with 20% Discount on This Report:


Drug Tests Services Market Challenges and Risks:

Here are some key challenges and risks associated with the drug testing services market:

Regulatory Compliance: The drug testing industry is subject to various regulations and standards, which can vary by region and industry. Ensuring compliance with these regulations, such as the U.S. Department of Transportation’s drug testing regulations, is crucial. Non-compliance can lead to legal and financial consequences.

Privacy Concerns: Drug testing involves collecting sensitive personal information, including medical data and drug test results. Safeguarding the privacy and confidentiality of individuals’ information is essential to maintain trust and comply with privacy laws and regulations.

Accuracy and Reliability: The accuracy and reliability of drug test results are paramount. False-positive or false-negative results can have serious consequences for individuals and organizations. Ensuring the quality of testing procedures and equipment is a constant challenge.

Evolving Drug Trends: The landscape of illicit drugs and substances is constantly evolving. Drug testing services must keep up with new drugs and substances, which can be challenging due to the lack of standardized testing methods for emerging substances.

About Us:

Infinity Business Insights is a market research company that offers market and business research intelligence all around the world. We are specialized in offering services in various industry verticals to recognize their highest-value chance, address their most analytical challenges, and alter their work.

Contact Us:

Sales Co-Ordinator

International: +1-518-300-3575

Email: inquiry@infinitybusinessinsights.com

Website: https://www.infinitybusinessinsights.com

CDN Newswire